TANGO THERAPEUTICS INC's ticker is and the CUSIP is 87583X109. A total of 59 filers reported holding TANGO THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $59,415,631 | +297.7% | 5,276,699 | +17.3% | 1.33% | +309.6% |
Q2 2023 | $14,940,000 | -15.9% | 4,500,000 | 0.0% | 0.32% | -19.6% |
Q1 2023 | $17,775,000 | -45.5% | 4,500,000 | 0.0% | 0.40% | -52.1% |
Q4 2022 | $32,625,000 | +100.3% | 4,500,000 | 0.0% | 0.84% | +91.8% |
Q3 2022 | $16,290,000 | -20.1% | 4,500,000 | 0.0% | 0.44% | -24.0% |
Q2 2022 | $20,385,000 | -29.3% | 4,500,000 | +18.2% | 0.58% | +3.2% |
Q1 2022 | $28,849,000 | -12.1% | 3,805,929 | +26.9% | 0.56% | -11.1% |
Q4 2021 | $32,820,000 | -15.4% | 3,000,000 | 0.0% | 0.63% | -23.9% |
Q3 2021 | $38,790,000 | – | 3,000,000 | – | 0.83% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP IV, LLC | 19,363,975 | $70,098,000 | 40.96% |
Boxer Capital, LLC | 6,871,642 | $24,875,000 | 1.40% |
TCG Crossover Management, LLC | 1,172,250 | $4,244,000 | 1.27% |
Cormorant Asset Management, LP | 4,116,949 | $14,903,000 | 1.04% |
Bain Capital Life Sciences Investors, LLC | 1,921,790 | $6,957,000 | 0.83% |
Samsara BioCapital, LLC | 630,000 | $2,281,000 | 0.53% |
EcoR1 Capital, LLC | 4,201,414 | $15,209,000 | 0.45% |
Southpoint Capital Advisors LP | 4,500,000 | $16,290,000 | 0.44% |
HARVARD MANAGEMENT CO INC | 708,385 | $2,564,000 | 0.32% |
Avoro Capital Advisors LLC | 1,550,000 | $5,611,000 | 0.10% |